Researchers have successfully used CRISPR/Cas9 to limit the impact of schistosomiasis and liver fluke infection, which affects more than a quarter of a billion people in Southeast Asia, sub-Saharan Africa, and Latin America.
Source: Medicine Science Daily
Gene-editing tool CRISPR/Cas9 shown to limit impact of certain parasitic diseases
January 15th, 2019 | Posted by in UncategorizedYou can follow any responses to this entry through the RSS 2.0 You can leave a response, or trackback.
Leave a Reply